Biomedical Systems

biomedsys.com

Biomedical Systems is a premier global provider of centralized diagnostic services.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

J&J LAUNCHES ‘MULTI-PRONGED’ CORONAVIRUS RESPONSE

PharmaTimes | January 30, 2020

news image

The company has initiated efforts to broadly collaborate with others in order to screen a library of antiviral therapies, hoping to identify compounds with antiviral activity against the virus – which is also known as 2019-nCoV or Wuhan coronavirus. Using its AdVac and PER.C6 technologies - the same technologies that were used in the development and manufacturing of Janssen's investigational Ebola vaccine - J&J has revealed plans to try and rapidly upscale production of the optimal...

Read More

IN THE WORLD OF BIG PHARMA, AN ITALIAN ORAL SPRAY SURVIVES

Dr ZinX | July 10, 2020

news image

Yonah S. Tehrani, MD on the potential benefit of the Dr ZinX Zinc + Hinokitiol combination: "The antiviral effects and benefits of Zinc and Hinokitiol may have a tremendous impact on affected individuals and health care systems worldwide." Zinc is a mineral of critical importance to the proper functioning of the immune system in all age groups. Zinc deficiency may result in low resistance to viruses and bacteria. Studies dating back to 1974 have shown that zinc supplemen...

Read More

Business Insights

DICERNA ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD FOR NOVO NORDISK TENDER OFFER TO ACQUIRE DICERNA

Dicerna Pharmaceuticals, Inc. | December 27, 2021

news image

Dicerna Pharmaceuticals, Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, 2021. As previously announced on November 18, 2021, Novo Nordisk commenced a cash tender offer to purchase all outstanding shares of Dicerna common stock for $38.25 per share in cash, without interest and subject to any wit...

Read More

Pharma Tech

ACROBIOSYSTEMS ANEURO PARTNERS WITH DIAGNOSTIC BIOCHIPS TO ACCELERATE NEUROSCIENCE DRUG DISCOVERY

PRNewswire | June 19, 2023

news image

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field potential an...

Read More
news image

J&J LAUNCHES ‘MULTI-PRONGED’ CORONAVIRUS RESPONSE

PharmaTimes | January 30, 2020

The company has initiated efforts to broadly collaborate with others in order to screen a library of antiviral therapies, hoping to identify compounds with antiviral activity against the virus – which is also known as 2019-nCoV or Wuhan coronavirus. Using its AdVac and PER.C6 technologies - the same technologies that were used in the development and manufacturing of Janssen's investigational Ebola vaccine - J&J has revealed plans to try and rapidly upscale production of the optimal...

Read More
news image

IN THE WORLD OF BIG PHARMA, AN ITALIAN ORAL SPRAY SURVIVES

Dr ZinX | July 10, 2020

Yonah S. Tehrani, MD on the potential benefit of the Dr ZinX Zinc + Hinokitiol combination: "The antiviral effects and benefits of Zinc and Hinokitiol may have a tremendous impact on affected individuals and health care systems worldwide." Zinc is a mineral of critical importance to the proper functioning of the immune system in all age groups. Zinc deficiency may result in low resistance to viruses and bacteria. Studies dating back to 1974 have shown that zinc supplemen...

Read More
news image

Business Insights

DICERNA ANNOUNCES EXPIRATION OF HART-SCOTT-RODINO ACT WAITING PERIOD FOR NOVO NORDISK TENDER OFFER TO ACQUIRE DICERNA

Dicerna Pharmaceuticals, Inc. | December 27, 2021

Dicerna Pharmaceuticals, Inc. announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, 2021. As previously announced on November 18, 2021, Novo Nordisk commenced a cash tender offer to purchase all outstanding shares of Dicerna common stock for $38.25 per share in cash, without interest and subject to any wit...

Read More
news image

Pharma Tech

ACROBIOSYSTEMS ANEURO PARTNERS WITH DIAGNOSTIC BIOCHIPS TO ACCELERATE NEUROSCIENCE DRUG DISCOVERY

PRNewswire | June 19, 2023

ACROBiosystems, through ACRO Certify and under its Aneuro brand, recently announced the launch of in vivo electrophysiology solutions for neuroscience research with Diagnostic Biochips. Together, two companies are committed to a collaborative effort to accelerate neurological drug discovery and commercialization. Electrophysiology is a critical part of neuroscience research, especially when attempting to elucidate the neural network. Monitoring the brain's field potential an...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us